GoodRx Holdings, Inc.

NasdaqGS:GDRX Stock Report

Market Cap: US$1.9b

GoodRx Holdings Management

Management criteria checks 2/4

GoodRx Holdings' CEO is Scott Wagner, appointed in Apr 2023, has a tenure of 1.58 years. total yearly compensation is $10.14M, comprised of 5% salary and 95% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $1.97M. The average tenure of the management team and the board of directors is 2.5 years and 7.3 years respectively.

Key information

Scott Wagner

Chief executive officer

US$10.1m

Total compensation

CEO salary percentage5.0%
CEO tenure1.6yrs
CEO ownership0.1%
Management average tenure2.5yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

Oct 29
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon

GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade)

Oct 26

GoodRx Holdings: Failing To Gain Much Traction

Oct 08

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Sep 22
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

GoodRx Q2 Earnings Preview

Jul 31

GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

Jul 12
GoodRx Holdings (NASDAQ:GDRX) Could Easily Take On More Debt

GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Jun 09
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 30% Price Boost Is Out Of Tune With Revenues

Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

Jun 06
Returns On Capital At GoodRx Holdings (NASDAQ:GDRX) Paint A Concerning Picture

GoodRx: Encouraging Profit Stabilization (Rating Upgrade)

May 28

GoodRx Holdings: Large TAM Continues To Support Growth

Mar 20

GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Mar 07
GoodRx Holdings, Inc. (NASDAQ:GDRX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

Mar 01
Is GoodRx Holdings, Inc. (NASDAQ:GDRX) Trading At A 24% Discount?

GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

Feb 12
GoodRx Holdings (NASDAQ:GDRX) Has A Rock Solid Balance Sheet

GoodRx: Cost Saving Is A Strong Value Proposition To Consumers

Jan 23

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Jan 22
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

GoodRx Stock Spikes After Receiving A Strong Dose Of Performance

Jan 11

What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

Dec 02
What Is GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Share Price Doing?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Sep 12
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

Jul 14
An Intrinsic Calculation For GoodRx Holdings, Inc. (NASDAQ:GDRX) Suggests It's 41% Undervalued

GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

May 27
GoodRx Holdings' (NASDAQ:GDRX) Returns On Capital Not Reflecting Well On The Business

Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

May 05
Some Confidence Is Lacking In GoodRx Holdings, Inc. (NASDAQ:GDRX) As Shares Slide 27%

Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

May 05
Investors Give GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares A 27% Hiding

Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

Mar 23
Is There An Opportunity With GoodRx Holdings, Inc.'s (NASDAQ:GDRX) 45% Undervaluation?

GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

Feb 07
GoodRx Holdings (NASDAQ:GDRX) May Have Issues Allocating Its Capital

CEO Compensation Analysis

How has Scott Wagner's remuneration changed compared to GoodRx Holdings's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$16m

Jun 30 2024n/an/a

-US$59m

Mar 31 2024n/an/a

-US$7m

Dec 31 2023US$10mUS$512k

-US$9m

Compensation vs Market: Scott's total compensation ($USD10.14M) is above average for companies of similar size in the US market ($USD5.27M).

Compensation vs Earnings: Insufficient data to compare Scott's compensation with company performance.


CEO

Scott Wagner (53 yo)

1.6yrs

Tenure

US$10,144,526

Compensation

Mr. Scott W. Wagner serves as Interim Chief Executive Officer at GoodRx Holdings, Inc. since April 25, 2023 and serves as its Principal Operating Officer since February 15, 2024. He serves as Head of Strat...


Leadership Team

NamePositionTenureCompensationOwnership
Trevor Bezdek
Co-founder & Chairman of the Board13.2yrsUS$811.53k1.42%
$ 26.4m
Scott Wagner
Interim CEO & Principal Operating Officer1.6yrsUS$10.14m0.11%
$ 2.0m
Douglas Hirsch
Co-founder13.2yrsUS$784.86k1.42%
$ 26.4m
Karsten Voermann
Chief Financial Officer4.7yrsUS$902.24k0.072%
$ 1.3m
Romin Nabiey
Chief Accounting Officer2.6yrsUS$2.58m0.020%
$ 363.3k
Bansi Nagji
President of Healthcare4.4yrsUS$4.91m0.065%
$ 1.2m
Mike Walsh
President & Executive VP of Prescription Marketplaceless than a yearno datano data
Nitin Shingate
Chief Technology Officer1.9yrsno datano data
Aubrey Reynolds
Director of Investor Relationsno datano datano data
Gracye Cheng
General Counsel & Secretaryno datano datano data
Andrew Slutsky
Chief Marketing Officer1.3yrsUS$864.80k0%
$ 0
Vina Leite
Chief People Officer2.5yrsno datano data

2.5yrs

Average Tenure

53yo

Average Age

Experienced Management: GDRX's management team is considered experienced (2.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Trevor Bezdek
Co-founder & Chairman of the Board13.2yrsUS$811.53k1.42%
$ 26.4m
Douglas Hirsch
Co-founder13.2yrsUS$784.86k1.42%
$ 26.4m
Gregory Mondre
Independent Director6.1yrsno datano data
Dipanjan Deb
Independent Director9.1yrsno datano data
Ian T. Clark
Directorless than a yearno datano data
Agnes Rey-Giraud
Independent Director8.4yrsUS$269.53k0.079%
$ 1.5m
Christopher Adams
Independent Director9.1yrsno datano data
Simon Patterson
Directorless than a yearno datano data
Kelly Kennedy
Independent Directorless than a yearUS$448.63kno data
Ronald Bruehlman
Directorno datano datano data

7.3yrs

Average Tenure

54yo

Average Age

Experienced Board: GDRX's board of directors are considered experienced (7.3 years average tenure).